GKOS
Price
$84.00
Change
-$3.00 (-3.45%)
Updated
Apr 4, 02:38 PM (EDT)
Capitalization
4.61B
26 days until earnings call
TMDX
Price
$66.67
Change
-$4.29 (-6.05%)
Updated
Apr 4, 02:55 PM (EDT)
Capitalization
2.4B
32 days until earnings call
Ad is loading...

GKOS vs TMDX

Header iconGKOS vs TMDX Comparison
Open Charts GKOS vs TMDXBanner chart's image
Glaukos
Price$84.00
Change-$3.00 (-3.45%)
Volume$640
Capitalization4.61B
TransMedics Group
Price$66.67
Change-$4.29 (-6.05%)
Volume$650
Capitalization2.4B
GKOS vs TMDX Comparison Chart
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GKOS vs. TMDX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and TMDX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GKOS: $87.00 vs. TMDX: $70.96)
Brand notoriety: GKOS and TMDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GKOS: 216% vs. TMDX: 93%
Market capitalization -- GKOS: $4.61B vs. TMDX: $2.4B
GKOS [@Medical Specialties] is valued at $4.61B. TMDX’s [@Medical Specialties] market capitalization is $2.4B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 0 FA rating(s) are green whileTMDX’s FA Score has 0 green FA rating(s).

  • GKOS’s FA Score: 0 green, 5 red.
  • TMDX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GKOS and TMDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 5 TA indicator(s) are bullish while TMDX’s TA Score has 6 bullish TA indicator(s).

  • GKOS’s TA Score: 5 bullish, 4 bearish.
  • TMDX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TMDX is a better buy in the short-term than GKOS.

Price Growth

GKOS (@Medical Specialties) experienced а -16.04% price change this week, while TMDX (@Medical Specialties) price change was +0.74% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.00%. For the same industry, the average monthly price growth was -2.48%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

GKOS is expected to report earnings on Apr 30, 2025.

TMDX is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (-6.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than TMDX($2.4B). TMDX YTD gains are higher at: 13.809 vs. GKOS (-41.977). TMDX has higher annual earnings (EBITDA): -7.7M vs. GKOS (-82.12M). TMDX has more cash in the bank: 395M vs. GKOS (295M). GKOS has less debt than TMDX: GKOS (384M) vs TMDX (516M). GKOS has higher revenues than TMDX: GKOS (315M) vs TMDX (242M).
GKOSTMDXGKOS / TMDX
Capitalization4.61B2.4B192%
EBITDA-82.12M-7.7M1,066%
Gain YTD-41.97713.809-304%
P/E RatioN/AN/A-
Revenue315M242M130%
Total Cash295M395M75%
Total Debt384M516M74%
FUNDAMENTALS RATINGS
GKOS vs TMDX: Fundamental Ratings
GKOS
TMDX
OUTLOOK RATING
1..100
866
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
5058
SMR RATING
1..100
9547
PRICE GROWTH RATING
1..100
6458
P/E GROWTH RATING
1..100
53100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMDX's Valuation (78) in the Medical Specialties industry is in the same range as GKOS (93). This means that TMDX’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (50) in the Medical Specialties industry is in the same range as TMDX (58). This means that GKOS’s stock grew similarly to TMDX’s over the last 12 months.

TMDX's SMR Rating (47) in the Medical Specialties industry is somewhat better than the same rating for GKOS (95). This means that TMDX’s stock grew somewhat faster than GKOS’s over the last 12 months.

TMDX's Price Growth Rating (58) in the Medical Specialties industry is in the same range as GKOS (64). This means that TMDX’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (53) in the Medical Specialties industry is somewhat better than the same rating for TMDX (100). This means that GKOS’s stock grew somewhat faster than TMDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSTMDX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSPCX97.94N/A
N/A
Fidelity Select Insurance Port
ALVAX22.28N/A
N/A
American Beacon Large Cap Value A
CSPFX64.57N/A
N/A
American Funds SMALLCAP World 529F
LMVWX27.65N/A
N/A
Lord Abbett Focused Small Cap Value R6
FEQAX12.73N/A
N/A
Fidelity Advisor Hedged Equity Fund A

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-13.03%
ISRG - GKOS
46%
Loosely correlated
-2.45%
RDNT - GKOS
45%
Loosely correlated
-5.71%
NTRA - GKOS
43%
Loosely correlated
-3.14%
ALGN - GKOS
42%
Loosely correlated
-5.94%
AORT - GKOS
42%
Loosely correlated
-3.63%
More

TMDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with RDNT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
-2.94%
RDNT - TMDX
38%
Loosely correlated
-5.71%
RXST - TMDX
33%
Poorly correlated
-37.94%
GKOS - TMDX
32%
Poorly correlated
-13.03%
LIVN - TMDX
32%
Poorly correlated
-5.11%
ALGN - TMDX
30%
Poorly correlated
-5.94%
More